Vis enkel innførsel

Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals

dc.contributor.authorNygård, Ståle
dc.contributor.authorNygård, Mari
dc.contributor.authorOrumaa, Madleen
dc.contributor.authorHansen, Bo Lars Thorvald Terning
dc.date.accessioned2024-02-21T09:18:29Z
dc.date.available2024-02-21T09:18:29Z
dc.date.created2023-09-26T08:55:02Z
dc.date.issued2023
dc.identifier.citationVaccine. 2023, 41 (37), 5469-5476.
dc.identifier.issn0264-410X
dc.identifier.urihttps://hdl.handle.net/11250/3118904
dc.language.isoeng
dc.titleQuadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals
dc.title.alternativeQuadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber5469-5476
dc.source.volume41
dc.source.journalVaccine
dc.source.issue37
dc.identifier.doi10.1016/j.vaccine.2023.07.031
dc.identifier.cristin2178787
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail
Filnavn:
1-s2.0-S0264410X23008526-main.pdf
Størrelse:
1.018Mb
Format:
PDF
Åpne

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel